Please login to the form below

Not currently logged in
Email:
Password:

e-Therapeutics appoints new CEO

Dr Raymond Barlow joins firm from Amgen

UK-based drug discovery and development firm e-Therapeutics appoints Dr Raymond Barlow as its new CEO.

Prior to e-Therapeutics, Barlow worked for a number of global pharma companies, including AstraZeneca as its director of corporate development and most recently at Amgen working on deals with Boehringer Ingelheim, GlaxoSmithKline and Geneta.

He said: “e-therapeutics is at the forefront of a new wave of science and has created a unique, computational-based drug discovery platform. This platform uses a range of truly cutting-edge technologies, including artificial intelligence.

“I am looking forward to engaging with our key stakeholders as well as subsequently positioning and promoting the company to an industry which needs the assets and solutions we can provide.”

10th April 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...